Balloon catheter aims to supercharge CPR and save more lives

NCT ID NCT06793033

Recruiting now Disease control Sponsor: neurescue Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called NEURESCUE, a balloon catheter inserted into the leg artery that inflates to redirect blood to the heart and brain during cardiac arrest. Researchers will compare standard CPR plus the device against CPR alone in 84 adults with witnessed cardiac arrest and non-shockable heart rhythms. The goal is to see if the device helps restore a shockable rhythm or return of spontaneous circulation safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NEURESCUE catheter (aortic balloon occlusion device)
What this could lead to: If it works, this device could help more people survive cardiac arrest by quickly redirecting blood to the heart and brain during CPR.
What could go wrong: This is a small early-stage trial (84 people) testing safety and feasibility. The device is invasive and may cause complications like vessel damage or bleeding. Success in this study does not guarantee broader effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC ARREST (CA) CARDIOPULMONARY ARREST

Contacts and locations

Locations

Charité - Universitätsklinikum Berlin
RECRUITING

Berlin, 12203, Germany
University Hospital Heidelberg
RECRUITING

Heidelberg, 69120, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.